These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine. Toba H, Nakagawa Y, Miki S, Shimizu T, Yoshimura A, Inoue R, Asayama J, Kobara M, Nakata T. Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774 [Abstract] [Full Text] [Related]
4. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Sainz J, Wangensteen R, Rodríguez Gómez I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F. Am J Hypertens; 2005 Jun; 18(6):871-7. PubMed ID: 15925750 [Abstract] [Full Text] [Related]
5. Effect of chronic NG-nitro-L-arginine methyl ester (L-NAME) on blood pressure and renal function in conscious uninephrectomized spontaneously hypertensive rats. Reverte M, Flores O, Gallego B, Lestón A, López-Novoa JM. Can J Physiol Pharmacol; 1998 Jan; 76(1):63-7. PubMed ID: 9564550 [Abstract] [Full Text] [Related]
6. Chronic alpha1-adrenergic blockade improves hypertension and renal injury in L-NAME and low-renin L-NAME-DOCA hypertensive rats. Wangensteen R, O'Valle F, Del Moral R, Vargas F, Osuna A. Med Sci Monit; 2002 Sep; 8(9):BR378-84. PubMed ID: 12221376 [Abstract] [Full Text] [Related]
7. Effect of maturation on renal Na+/K+-atpase and its susceptibility to nitric oxide-deficient hypertension in rats. Javorková V, Vlkovicova J, Kunes J, Pechanova O, Zicha J, Vrbjar N. Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):617-23. PubMed ID: 17581218 [Abstract] [Full Text] [Related]
11. Characterization of the contractile 5-hydroxytryptamine receptor in the autoperfused kidney of L-NAME hypertensive rats. Morán A, de Urbina AV, Martín ML, Rodríguez-Barbero A, Román LS. Eur J Pharmacol; 2009 Oct 12; 620(1-3):90-6. PubMed ID: 19699736 [Abstract] [Full Text] [Related]
18. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester. López RM, Ortíz CS, Ruíz A, Vélez JM, Castillo C, Castillo EF. Fundam Clin Pharmacol; 2004 Dec 12; 18(6):669-77. PubMed ID: 15548238 [Abstract] [Full Text] [Related]
19. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME). Linardi A, Panunto PC, Ferro ES, Hyslop S. Biochem Pharmacol; 2004 Jul 15; 68(2):205-14. PubMed ID: 15193992 [Abstract] [Full Text] [Related]
20. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. Bagnost T, Berthelot A, Bouhaddi M, Laurant P, André C, Guillaume Y, Demougeot C. J Hypertens; 2008 Jun 15; 26(6):1110-8. PubMed ID: 18475148 [Abstract] [Full Text] [Related] Page: [Next] [New Search]